Grzegorz Goñda
Keine laufenden Positionen mehr
Karriereverlauf von Grzegorz Goñda
Ehemalige bekannte Positionen von Grzegorz Goñda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KBC Securities NV (Poland) | Analyst-Equity | 01.02.2005 | 01.02.2005 |
| ERNE VENTURES SA | Direktor/Vorstandsmitglied | 21.07.2010 | - |
Statistik
International
| Polen | 3 |
Operativ
| Director/Board Member | 1 |
| Analyst-Equity | 1 |
Sektoral
| Retail Trade | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Erne Ventures SA
 Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
| KBC Securities NV (Poland) | Finance |
- Börse
- Insiders
- Grzegorz Goñda
- Erfahrung
